References

Awareness on asymptomatic target-organ damage in hypertensive patients

G Crippa, D Zabzuni, A Cassi, E Bravi, G Peracchi, E Passera, G Santi
Journal of the American Society of Hypertension 9 (4), e117
  2015
COMPARISON BETWEEN NORMAL INTRAVENOUS INFUSION AND INTRAVENOUS INFUSION THROUGHT ELASTOMERIC PUMP OF ILOPROST: EVALUATION OF THE EFFECTIVENESS AND SIDE EFFECTS

E Bravi, E Arrigoni, G Crippa, A Ariani, C Concesi
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 32 (2), S112-S112
  2014
Evaluation of cardiovascular risk factors in hypertensive subjects: comparison between patients’ self-assessment and objective measurement by the physician

G Crippa, D Zabzuni, E Bravi, A Cassi
Journal of the American Society of Hypertension 8 (4), e135
  2014
Department of Internal Medicine and Renal Unit, Piacenza, Italy.

G Crippa, L Scarpioni
Diuretics: Basic, Pharmacological, and Clinical Aspects: Proceedings of the …
  2012
Effect on blood pressure of dietary integration with grana padano cheese

G Crippa, M BOSI, A Cassi, F ROSSI
Journal of Clinical Hypertension 14 (suppl. 1), 18-18
1 2012
BLOOD PRESSURE LOWERING EFFECT OF DIETARY INTEGRATION WITH GRANA PADANO CHEESE IN HYPERTENSIVE PATIENTS: 2C. 02

G Crippa, M Bosi, A Cassi, L Fiorentini, F Rossi
Journal of Hypertension 29, e27
  2011
AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT BY USING THE BPTRU DEVICE FOR THE DIAGNOSIS OF RESISTANT HYPERTENSION: PP. 4.95

G Crippa, A Cassi, M Bosi, ML Fares
Journal of Hypertension 29, e175
  2011
THE BEDTIME DOSING OF BARNIDIPINE HYDROCHLORIDE RESTORES CIRCADIAN RHYTHM IN NONDIPPER HYPERTENSIVE PATIENTS: PP. 33.303

G Crippa, A Cassi, E Bravi, ML Fares, P Cavallotti
Journal of Hypertension 28, e541
1 2010
COMPARISON BETWEEN AMBULATORY BLOOD PRESSURE AND REPEATED OFFICE BLOOD PRESSURE MEASUREMENT FOR THE DIAGNOSIS OF MASKED AND WHITE COAT HYPERTENSION: PP. 3.107

G Crippa, A Cassi, ML Fares, E Bravi, P Cavallotti
Journal of Hypertension 28, e80
1 2010
HOME BLOOD PRESSURE VERSUS A SERIES OF IN-OFFICE BLOOD PRESSURE (ROBP) MEASUREMENTS IN UNTREATED HYPERTENSIVE SUBJECTS

G Crippa, A Cassi, ML Fares, C Venturi, E Bravi, P Cavallotti
JOURNAL OF HYPERTENSION 27, S44-S44
  2009
IDENTIFICATION OF MASKED HYPERTENSION BY USING REPEATED OFFICE BLOOD PRESSURE (ROBP) MEASUREMENTS

G Crippa, A Cassi, C Venturi, E Bravi, ML Fares, P Cavallotti
JOURNAL OF HYPERTENSION 27, S44-S44
  2009
Validity of a series of repeated office blood pressure measurements for the diagnosis and the control of hypertension

G Crippa, A Cassi, C Venturi, E Bravi, P Cavallotti
JOURNAL OF HYPERTENSION 26, S290-S291
  2008
Normalcy values for repeated office blood pressure (ROBP) measurement: comparison with ambulatory blood pressure

G Crippa, A Cassi, C Venturi, E Bravi, P Cavallotti
JOURNAL OF HYPERTENSION 26, S293-S293
1 2008
USEFULNESS OF A SERIES OF REPEATED IN-OFFICE BLOOD PRESSURE (ROBP) MEASUREMENTS FOR THE DIAGNOSIS OF WHITE-COAT HYPERTENSION

G Crippa, A Cassi, C Venturi, E Bravi, P Cavallotti
European Journal of Internal Medicine 19, S35
  2008
PSYCHOLOGICAL FACTORS AND PROFILE ASSOCIATED WITH WHITE-COAT PHENOMENON

G Crippa, P Bertoletti, O Bettinardi, G Calandra, A Mosti, P Cavallotti
European Journal of Internal Medicine 19, S6
  2008
Repeated office blood pressure measurements (ROBP) for the diagnosis of white-coat or sustained hypertension

G Crippa, A Cassi, C Venturi, C Prati, P Cavallotti
JOURNAL OF HYPERTENSION 25, S160-S160
  2007
Repeated office blood pressure measurement for the evaluation of treatment efficacy

G Crippa, A Cassi, C Venturi, C Prati, P Cavallotti
JOURNAL OF HYPERTENSION 25, S159-S160
  2007
We-P11: 139 Usefulness of repeated office blood pressure to define BP levels of the metabolic syndrome

G Crippa, A Cassi, C Venturi, P Cavallotti
Atherosclerosis Supplements 7 (3), 376
  2006
The aldosterone antagonist and facultative diuretic eplerenone: a critical review

AJ Reyes, WP Leary, G Crippa, MFC Maranhão, …
European journal of internal medicine 16 (3), 145-153
24 2005
P-56 MP-19: Repeated office blood pressure (ROBP) measurement for the diagnosis of white-coat or sustained hypertension

G Crippa, G Ragni, C Venturi, E Arrigoni, D Pancotti
American Journal of Hypertension 18 (S4), 28A-28A
1 2005
P-57: Repeated office blood pressure (ROBP) measurement for the evaluation of antihypertensive treatment efficacy

G Crippa, G Ragni, C Venturi, E Arrigoni, D Pancotti
American Journal of Hypertension 18 (S4), 28A-29A
1 2005
P-189: Prevalence of antihypertensive drug monotherapy at a specialty hypertension clinic

DY Chua, R Behara, P Meyer, K Karavolas, HR Black, WJ Elliott
American Journal of Hypertension 17 (S1), 103A-103A
1 2004
P-11: Usefulness of repeated office blood pressure measurements to disclose white coat hypertension

G Crippa, C Venturi, M Giorgi-Pierfranceschi, E Sverzellati
American Journal of Hypertension 17 (S1), 37A-37A
  2004
P-191: Effect of antihypertensive treatment with telmisartan or lercanidipine on blood pressure variability

G Crippa, M Giorgi-Pierfranceschi, C Venturi, E Sverzellati
American Journal of Hypertension 17 (S1), 103A-103A
  2004
EFFECT OF NEBIVOLOL OR LERCANIDIPINE ON AMBULATORY BLOOD PRESSURE VARIABILITY.: P 534

G Crippa, C Venturi, E Sverzellati
Journal of Hypertension 22, S145
  2004
REPEATED OFFICE BLOOD PRESSURE MEASUREMENTS WITH AUTOMATED DEVICE TO EVALUATE BLOOD PRESSURE STATUS: P 700

G Crippa, E Sverzellati, C Venturi, P Antoniotti
Journal of Hypertension 22, S191
  2004
P-199: Effect of nebivolol or lercanidipine on ambulatory blood pressure variability in patients with mild-to-moderate essential hypertension

G Crippa, C Venturi, GC Cararra
American Journal of Hypertension 16 (S1), 111A
  2003
P-19: Repeated office blood pressure measurement by automated device to evaluate blood pressure control

G Crippa, E Sverzellati, C Venturi, P Antoniotti
American Journal of Hypertension 16 (S1), 46A-46A
3 2003
Psychological constructs involved in white-coat phenomenon

G Crippa, P Bertoletti, G Calandra, E Sverzellati, O Bettinardi
American Journal of Hypertension 15 (S3), 83A-83A
  2002
P-48: Effect of antihypertensive treatment with carvedilol or lercanidipine on ambulatory blood pressure variability

G Crippa, C Venturi, G Carrara
American Journal of Hypertension 15 (S3), 50A-50A
1 2002
Microalbuminuria in essential hypertension.

G Crippa
Journal of human hypertension 16 (3)
21 2002
Pilot clinical study of a new dopaminergic in heart failure

G Crippa, AJ Reyes, M Giogi-Pierfranceschi, MG Meny, E Sverzellati
EUROPEAN HEART JOURNAL 22, 498-498
1 2001
C025: Psychological constructs involved in emotional blood pressure response and white coat phenomenon

G Crippa, O Bettinardi, G Calandra, PL Bertoletti, P Mizzi, E Sverzellati, …
American Journal of Hypertension 13 (S2), 218A
  2000
C024: Bettering blood pressure control in clinical practice: role of ambulatory blood pressure monitoring

G Crippa, E Sverzellati, P Antoniotti, GC Carrara
American Journal of Hypertension 13 (S2), 218A
  2000
UTILITA E LIMITI DEL MONITORAGGIO AMBULATORIALE DELLA PRESSIONE ARTERIOSA

G Crippa
ANNALI ITALIANI DI MEDICINA INTERNA 15 (1), 63-69
  2000
[The usefulness and limits of the ambulatory monitoring of arterial pressure]

G Crippa
Annali italiani di medicina interna: organo ufficiale della Societa italiana …
2 1999
Psychological constructs associated with emotional blood pressure response and white coat phenomenon.

G Crippa, P Bertoletti, O Bettinardi, G Calandra, GC Carrara
Annali italiani di medicina interna: organo ufficiale della Societa italiana …
5 1999
Severe postpartum hypertension and reversible cerebral angiopathy associated with ergot derivative (methergoline) administration.

G Crippa, E Sverzellati, D Pancotti, GC Carrara
Annali italiani di medicina interna: organo ufficiale della Società italiana …
10 1999
Effect of nifedipine on urinary protein excretion in hypertensive patients

G Crippa, E Sverzellati, P Antoniotti, GC Carrara
American Journal of Hypertension 12 (4), 117
1 1999
Magnesium and cardiovascular drugs: interactions and therapeutic role.

G Crippa, E Sverzellati, M Giorgi-Pierfranceschi, GC Carrara
Annali italiani di medicina interna: organo ufficiale della Società italiana …
23 1998
Lung water is a critical determinant of functional capacity in congestive heart failure

E Sverzellati, RD Espinas, M Giorgi-Pierfranceschi, MG Meny, G Crippa, …
Journal of Cardiac Failure 4 (3), 15
1 1998
Functional purport of the cardiothoracic ratio in congestive heart failure

E Sverzellati, MG Meny, G Crippa, RD Espinas, G Ragni, AJ Reyes
Journal of Cardiac Failure 4 (3), 44
1 1998
M002 Severe postpartum hypertension with reversible cerebral angiopathy associated with an ergot derivative (methergoline) administration

E Sverzellati, GL Landi, S Cammarata, D Pancotti, G Crippa
American Journal of Hypertension 11 (4), 199A
  1998
C003 Need of reference values from ambulatory blood pressure monitoring for the diagnosis of white coat hypertension

G Crippa, E Sverzellati, M Giorgi-Pierfranceschi, GC Carrera
American Journal of Hypertension 11 (4), 48A
  1998
Piacenza Civil Hospital, 29100 Piacenza Italy

G CRIPPA, M GIORGI-PIERFRANCESCHI
Magnesium: Current Status and New Developments: Theoretical, Biological and …
  1997
G38 Is white coat hypertension the first step of sustained hypertension?

G Crippa, E Sverzellati, G Ragni, M Giorgi-Pierfranceschi, GC Carrara
American Journal of Hypertension 10 (4), 69A
  1997
Magnesium in Liver Cirrhosis

G Crippa, M Giorgi-Pierfranceschi
Magnesium: Current Status and New Developments, 89-94
  1997
Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.

G Crippa, C Cagnoni, A Castelli, C Concesi, S Girometta, D Pancotti, …
La Clinica terapeutica 146 (5), 367-372
6 1995
C8-Once-daily treatment with lisinopril is effective throughout the 24 hours and does not cause nocturnal hypotension

G Crippa, E Sverzellati, M Giorgi-Pierfranceshi, GC Carrara
American Journal of Hypertension 8 (4), 176A
  1995
Untoward actions of diuretics in congestive heart failure

AJ Reyes, WP Leary, G Crippa, L Alcocer
PROGRESS IN PHARMACOLOGY AND CLINICAL PHARMACOLOGY 10, 131-131
4 1995
First clinical experience with the new oral dopaminergic CHF 1035 in congestive heart failure

G Crippa, A Umile, GC Carrara, AJ Reyes
J Heart Failure 2 (1)
5 1995
Treatment of chronic hepatitis C with alfa-interferon and ursodeoxycholic acid

C Cagnoni, A Castelli, C Concesi, G Crippa
GIORNALE ITALIANO DI RICERCHE CLINICHE E TERAPEUTICHE 15, 17-17
  1994
Terapia dell’epatite cronica attiva da HCV con alfa-IFN e UDCA. Linee guida in sede di valutazione prognostica

C Cagnoni, A Castelli, G Crippa, D Pancotti
GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE 46, 848-848
  1994
The decrease in thevolume factor’as a possible determinant of the antihypertensive effect of diuretics

AJ Reyes, JV Olhaberry, G Crippa
EXCERPTA MEDICA INTERNATIONAL CONGRESS SERIES 1023 (1), 535-535
  1993
How diuretics affect the cardiovascular system: A graph analysis

MI Ferreira, AJ Reyes, JV Olhaberry, G Crippa
EXCERPTA MEDICA INTERNATIONAL CONGRESS SERIES 1023 (1), 499-499
  1993
Indapamide induces hypokalaemia but not ventricular arrhythmias in hypertensive patients

G Crippa, L Lochetti, M Pagliara, M Gasperini, F Vergani
Diuretics IV: Chemistry, Pharmacology and Clinical Applications, 249-252
1 1993
USL 2 of Piacenza, ITALY.

G CRIPPA, A CASSI, R ZURLA, F VERGANI
Diuretics III: Chemistry, Pharmacology, and Clinical Applications …
  1990
Comparison of the acute diuretic effect of torasemide versus furosemide in healthy subjects and in cirrhotic patients

G Crippa, A Cassi, R Zurla
Diuretic III: Chemistry, Pharmacology, and Clinical Applications. Amsterdam …
2 1990
DEXTRAN DEPOSITS IN TISSUES OF PATIENTS UNDERGOING HEMODIALYSIS

G BERGONZI, G BASSALLO, C PATIES, A ZAMBIANCHI, PG POISETT, …
KIDNEY INTERNATIONAL 35 (2), 757-757
  1989
COMPARATIVE EVALUATION OF MUZOLIMINE SUBJECTS AND IN LIVER CIRRHOSIS.

G Crippa, L Scarpioni
Diuretics: Basic, Pharmacological, and Clinical Aspects: Proceedings of the …
  1987
Comparative Evaluation of Muzolimine and Furosemide in Healthy Subjects and in Liver Cirrhosis

G Crippa, L Scarpioni
Diuretics: Basic, Pharmacological, and Clinical Aspects, 426-428
  1987
Piretanide in the therapy of water-sodium retention in hepatic cirrhosis

L Scarpioni, G Crippa, MA Zanazzi
Giornale di clinica medica 63 (1), 57

Link a tutti i lavori